Cosmos Health Inc. (COSM)
COSMNASDAQ-CMOther Pharmaceuticals
$0.2674
-0.0375 (-12.30%) today
At the close, Nov 9, 4:00 PM ET. After hours $0.2678 –
- Market cap
- $26.95m
- P/E
- –
- EPS, last 4 quarters
- $-0.3600
- Dividend yield
- –
- Day range
- $0.2600 to $0.3000
- 52-week range
- $0.1616 to $0.8198
- Average volume
- 3.13m
- Previous close
- $0.3049
Analysts
1 coveringStrong Buy1 buy, 0 hold, 0 sell
Targets a year out average $1.40, +423.6% from here
Earnings
next estimate $-0.0400Next report Nov 13, 2026
Sep 2025
–
Dec 2025
–
Mar 2026
-100.0%
Jun 2026
-400.0%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $17.11m | $19.70m | $17.93m | $18.99m |
| Gross profit | $2.60m | $2.08m | $1.38m | $1.51m |
| Operating income | -$1.82m | -$11.41m | -$2.18m | -$2.93m |
| Net income | -$5.35m | -$10.15m | -$2.81m | -$6.09m |
Last four quarters: revenue $73.73m, margin -33.1%, free cash flow -$9.33m
News
8 latest- Cosmos Health Inc. Expects Q4 2026 U.S. Revenue of $15 Million and Gross Profit of $10.5 MillionFintel · Oct 22, 2026
- Cosmos Health Expands Into Saudi Arabia With Exclusive Distribution Deal; Stock Up RTTNews · Aug 20, 2026
- Cosmos Net Loss Widens In Q2 Despite Revenue Growth RTTNews · Aug 20, 2026
- Cosmos Health Expands Pharma Cell Partnership In Albania For Sky Premium Life Brand RTTNews · Jul 21, 2026
- Cosmos Expands Share Buyback To 4.49 Mln Shares; Plans To Continue Open Market Repurchase RTTNews · Jul 15, 2026
- Cosmos Health Launches Subscription-Based Purchasing Model For Health Brands; Stock Up RTTNews · Jul 13, 2026
- Cosmos Health Share Buyback Surpasses 4 Million Shares RTTNews · Jul 9, 2026
- Cosmos Health Preliminary Q2 Revenue Improves; Share Buyback Expands To 3.87 Mln Shares RTTNews · Jul 8, 2026
The company
Cosmos Health Inc. (NASDAQ: COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- cosmoshealthinc.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.